PMGC Holdings Inc.
0.8M
$0.03M
-0.82
$-6,595.29
No price alerts set. Add an alert to get notified!
-0.82
0.77
$-6,595.29
-93.79%
-253.14%
-75.65%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
ATXI
Avenue Therapeutics, Inc.
|
$0.29 | 4.69% | -0.25 | $923,231 | 0.00 |
|
BCTXZ
BriaCell Therapeutics Corp. Warrant
|
$0.11 | -4.09% | -0.26 | $207,400 | 0.00 |
|
DRMA
Dermata Therapeutics, Inc.
|
$1.47 | -5.16% | -0.17 | $1.00M | 0.00 |
|
MLEC
Moolec Science S.A.
|
$6.56 | -3.10% | -3.92 | $4.76M | 7.90 |
|
NCEL
NewcelX Ltd.
|
$2.41 | -0.41% | -0.45 | $1.08M | 0.00 |
|
NKGN
NKGen Biotech, Inc. Common Stock
|
$0.06 | -62.50% | -0.23 | $7.84M | -0.76 |
|
PBM
Psyence Biomedical Ltd.
|
$2.36 | -2.88% | -5.72 | $44,887 | 0.00 |
|
VRAX
Virax Biolabs Group Limited
|
$0.19 | 4.74% | -0.16 | $808,168 | 0.10 |
|
WINT
Windtree Therapeutics, Inc.
|
$0.01 | -6.00% | 0.00 | $316,863 | -1.11 |
|
XRTX
XORTX Therapeutics Inc.
|
$0.41 | 5.92% | -1.06 | $1.54M | 0.02 |
* Peer stocks are selected based on market capitalization and sector
$467.37
$1.82
$0.00
0.00%
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
